A pilot study of an anti-MRSA bio-engineered lacteal complex (anti-MRSA BLC) in a murine septicemia model

Immunopharmacology and Immunotoxicology

Volumn 28, Issue 4, 2006, Pages 601-607

  Stoff, Jesse A ^a   Nix, David E ^b   DeYoung, D W ^c  

^a Tiburon Laboratory   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Bio engineered Lacteal Complex (BLC); Methicillin Resistant Staphylococcus Aureus (MRSA); Murine Peritonitis; Sepsis; Toxemia

Indexed keywords

ANTIINFECTIVE AGENT; BIOENGINEERED LACTEAL COMPLEX; METICILLIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENGINEERING; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; IMMUNOGENICITY; IN VIVO STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PERITONITIS; PILOT STUDY; PRIORITY JOURNAL; SEPTICEMIA; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ANTI-INFECTIVE AGENTS; FLOW CYTOMETRY; METHICILLIN RESISTANCE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PERITONITIS; PILOT PROJECTS; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ANIMALIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MURINAE;

EID: 33845864713     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970601067045     Document Type: Article

References (12)

1. Louie, A.; Kaw, P.; Liu, W. et al. Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection. Antimicrob. Agents Chemother. 2001, 45, 845-851.
2. Emori, T.; Gaynes, P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 1993, 23, 255-259.
3. Lowy, F. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339, 520-532.
4. Smith, T.L.; Pearson, M.L.; Wilcox, K.R. et al. Emergence of vancomycin resistance in Staphylococcus aureus. N. Engl. J. Med. 1999, 340, 493-501.
5. Jevons, M.P.; Coe, A.W.; Parker, M.T. "Celbenin" resistant staphylococci. Br. Med. J. 1961, 1, 124-125.
6. Hrynewicz, W. Epidemiology of MRSA. Infect. (suppl. 2): 1999, S13-S16.
7. Tischbein, H. A new dawn for agriculture: A livestock healthcare revolution. Countryside 1976, 60, (8), 14-20.
8. Espersen, F.; Clemmensen, I.; Rhodes, J.M. et al. Human serum and plasma increase mouse mortality in Staphylococcus aureus intra-peritoneal infection. Acta Pathol. Microbiol. Immunol. Scand. Sect. 1984, B92, 305-310.
9. Knudsen, J.D.; Frimodt-Moller, N.; Espersen, F. Experimental Streptococcus pneumoniae infection in mice for studying the correlation of in vitro and in vivo activities of penicillin against pneumocci with various susceptibilities to penicillin. Antimicrob. Agents Chemother. 1995, 39, 1253-1258.
10. Yanke, S.J.; Olson, M.E.; Davies, H.D. et al. A CD-1 mouse model of infection with Staphylococcus aureus: influence of gender on infection with MRSA and MRSA isolates. Can. J. Microbiol. 2000, 46, 920-926.
11. Warren, G.L.; Gray, J.; Vernon, S.K. The in vitro action of mammalian sex hormones on Staphylococcus aureus. Chemotherapy (Basel) 1970, 15, 273-285.
12. Carlsten, H.; Nilsson, N.; Jonsson, R. et al. Differential effects of oestrogen in murine lupus: acceleration of glomerulonephritis and amelioration of T cell mediated lesions. J. Autoimmun. 1991, 4, 845-856.